Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Times Interest Earned (2020 - 2023)

Relay Therapeutics (RLAY) has disclosed Times Interest Earned for 4 consecutive years, with -$33725.7 as the latest value for Q1 2023.

  • On a quarterly basis, Times Interest Earned fell 1029.19% to -$33725.7 in Q1 2023 year-over-year; TTM through Dec 2023 was -$124333.3, a 772.44% decrease, with the full-year FY2020 number at -$3487.2, down 140.65% from a year prior.
  • Times Interest Earned was -$33725.7 for Q1 2023 at Relay Therapeutics, down from -$2986.7 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $4373.5 in Q4 2020 to a low of -$33725.7 in Q1 2023.
  • A 4-year average of -$9628.3 and a median of -$7321.4 in 2020 define the central range for Times Interest Earned.
  • Peak YoY movement for Times Interest Earned: soared 64.78% in 2022, then crashed 1029.19% in 2023.
  • Relay Therapeutics' Times Interest Earned stood at $4373.5 in 2020, then crashed by 293.92% to -$8481.0 in 2021, then skyrocketed by 64.78% to -$2986.7 in 2022, then plummeted by 1029.19% to -$33725.7 in 2023.
  • Per Business Quant, the three most recent readings for RLAY's Times Interest Earned are -$33725.7 (Q1 2023), -$2986.7 (Q1 2022), and -$8481.0 (Q1 2021).